Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT02973035

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02973035
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02973035. Randomized; no masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2020-01-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
Condition
Hypertension
Intervention (Drug)
Amlodipine
Intervention (Drug)
Valsartan
Lead sponsor
Asan Medical Center (class: other)
Collaborator
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct02973035
Content hash
323e78d76773e91bc609021fe61be4eb0af572c1b3b82ee32309a01ee729a888